| 2023 | MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2022 | MAFLD Predicts the Risk of Cardiovascular Disease Better than NAFLD in Asymptomatic Subjects with Health Check-Ups | DIGESTIVE DISEASES AND SCIENCES |
| 2014 | Maintaining remission in lamivudine-resistant patients with a virological response to adefovir add-on lamivudine after stopping lamivudine therapy. | LIVER INTERNATIONAL |
| 2017 | Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study
| GUT AND LIVER |
| 2020 | Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement
| LANCET GASTROENTEROLOGY & HEPATOLOGY |
| 2008 | MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection
| CARCINOGENESIS |
| 2023 | Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease | LIVER INTERNATIONAL |
| 2022 | Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study | DIABETES & METABOLISM |
| 2024 | Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease | GUT |
| 1999 | Mirizzi 증후군의 임상적 고찰
| Korean Journal of Pancreas and Biliary Tract |
| 2010 | Molecular and clinical characteristics of hepatitis B virus in Korea | JOURNAL OF MEDICAL VIROLOGY |
| 2024 | Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study | METABOLISM-CLINICAL AND EXPERIMENTAL |
| 2007 | MRP2 haplotypes confer differential susceptibility to toxic liver injury | PHARMACOGENETICS AND GENOMICS |
| 2019 | Multicenter Retrospective Risk Assessment of Esophageal Variceal Bleeding in Patients with Cirrhosis: An Acoustic Radiation Force Impulse Elastography-Based Prediction Model
| GUT AND LIVER |
| 2008 | Natural history of hepatitis B virus-related cirrhotic patients hospitalized to control ascites | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2020 | Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase | CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY |
| 2021 | Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis B | EUROPEAN JOURNAL OF INTERNAL MEDICINE |
| 2021 | Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2024 | Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
| 2022 | New Evidence of Oral Branched-Chain Amino Acid Supplementation on the Prognosis of Patients With Advanced Liver Disease
| CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY |
| 2014 | New Susceptibility and Resistance HLA-DP Alleles to HBV-Related Diseases Identified by a Trans-Ethnic Association Study in Asia
| PLOS ONE |
| 2023 | Next-generation sequencing analysis of hepatitis C virus resistance-associated substitutions in direct-acting antiviral failure in South Korea
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2012 | No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations
| BMC MEDICAL GENETICS |
| 2021 | No influence of hepatic steatosis on the 3-year outcomes of patients with quiescent chronic hepatitis B | JOURNAL OF VIRAL HEPATITIS |
| 2010 | Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression
| HEPATOLOGY INTERNATIONAL |
| 2011 | Non-invasive assessment of liver fibrosis: the gap between ideal and real | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2010 | Non-invasive assessment of liver fibrosis: time to move from cross-sectional studies to longitudinal ones. | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2014 | Non-invasive prediction of forthcoming cirrhosis-related complications
| WORLD JOURNAL OF GASTROENTEROLOGY |
| 2020 | Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk | AMERICAN JOURNAL OF GASTROENTEROLOGY |
| 2007 | Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B | LIVER INTERNATIONAL |
| 2023 | Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus-related liver cirrhosis | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2015 | Normal controlled attenuation parameter values: a prospective study of healthy subjects undergoing health checkups and liver donors in Korea | DIGESTIVE DISEASES AND SCIENCES |
| 2013 | Normal enhanced liver fibrosis (ELF) values in apparently healthy subjects undergoing a health check-up and in living liver donors in South Korea | LIVER INTERNATIONAL |
| 2012 | Normal liver elasticity values using acoustic radiation force impulse imaging: a prospective study in healthy living liver and kidney donors | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2012 | "Normal" liver stiffness values differ between men and women: a prospective study for healthy living liver and kidney donors in a native Korean population | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2011 | "Normal" range of alanine aminotransferase levels for Asian population | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2021 | Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy
| CANCERS |
| 2017 | Nucleos(t)ide Analogue Treatment for Patients With Hepatitis B Virus (HBV) e Antigen-Positive Chronic HBV Genotype C Infection: A Nationwide, Multicenter, Retrospective Study | JOURNAL OF INFECTIOUS DISEASES |
| 2013 | Number of target lesions for EASL and modified RECIST to predict survivals in hepatocellular carcinoma treated with chemoembolization
| CLINICAL CANCER RESEARCH |
| 2012 | Optimal time for restoring the reliability of liver stiffness measurement in patients with chronic hepatitis B experiencing acute exacerbation | JOURNAL OF CLINICAL GASTROENTEROLOGY |
| 2013 | Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma
| ONCOTARGETS AND THERAPY |
| 2016 | Outcome of adefovir add-on lamivudine rescue therapy of up to 5 years in patients with lamivudine-resistant chronic hepatitis B | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2024 | PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B | JOURNAL OF HEPATOLOGY |
| 2013 | Partial Virological Response to Adefovir Add-On Lamivudine Rescue Therapy in Patients with Lamivudine-Resistant Chronic Hepatitis B | DIGESTION |
| 2011 | Partial virological response to entecavir in treatment-naive patients with chronic hepatitis B. | ANTIVIRAL THERAPY |
| 2021 | Pathological predictive factors for late recurrence of hepatocellular carcinoma in chronic liver disease | LIVER INTERNATIONAL |
| 2016 | Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B) | JOURNAL OF HEPATOLOGY |
| 2013 | Performance evaluation of the HepB Typer-Entecavir kit for detection of entecavir resistance mutations in chronic hepatitis B
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2012 | Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis
| PLOS ONE |
| 2008 | Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection | LIVER INTERNATIONAL |
| 2021 | Pharmacokinetics and safety of evogliptin in hepatically impaired patients | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY |
| 2014 | Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B | GUT |
| 2008 | Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis.
| CANCER |
| 2007 | PIVKA-II Is a Useful Tumor Marker for Recurrent Hepatocellular Carcinoma after Surgical Resection | ONCOLOGY |
| 2023 | Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma
| FRONTIERS IN ENDOCRINOLOGY |
| 2023 | Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study | EUROPEAN JOURNAL OF INTERNAL MEDICINE |
| 2020 | Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
| HEPATOLOGY INTERNATIONAL |
| 2014 | Pre-S mutations of hepatitis B virus affect genome replication and expression of surface antigens | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2016 | Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response.
| GUT AND LIVER |
| 2023 | Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy
| JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION |
